0597-0137 : Gilotrif 30 mg Oral Tablet

Labeler: Boehringer Ingelheim Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Gilotrif
Dosage Form: Oral Tablet, Film Coated
Application #: NDA201292
Rev. Date: 


Markings: T30
Shapes:  Round
Colors:  Blue
Size (mm): 9
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0597-0137-30: 1 BOTTLE IN 1 CARTON (0597‑0137‑30) > 30 TABLET, FILM COATED IN 1 BOTTLE
  • 0597-0137-90: 1 BOTTLE IN 1 CARTON (0597‑0137‑90) > 30 TABLET, FILM COATED IN 1 BOTTLE

Active Ingredients:

  • Afatinib

Dosage Strength:

  • 30 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0597-0138 Gilotrif 40 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0141 Gilotrif 20 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.


Scan the QR code below to easily reference this data in the future:

NDC 0597-0137 QR Code

< Prev: 0597-0135Next: 0597-0138 >

Related Discussions:

Afatinib 40 mg
I need afatinib 40 mg very urgently but I cannot afford the present price levels in Venezuela nor the international one....

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 August 2015.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA